Voloridge Investment Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-56,353
| Closed | -$1.04M | – | 1559 |
|
|
2023
Q3 | $1.04M | Buy |
+56,353
| New | +$637K | 0.01% | 1085 |
|
|
2023
Q2 | – | Sell |
-166,327
| Closed | -$2.23M | – | 1623 |
|
|
2023
Q1 | $2.23M | Sell |
166,327
-104,114
| -38% | -$1.8M | 0.01% | 952 |
|
|
2022
Q4 | $3.35M | Sell |
270,441
-63,288
| -19% | -$896K | 0.02% | 802 |
|
|
2022
Q3 | $4.66M | Buy |
333,729
+21,253
| +7% | +$342K | 0.03% | 671 |
|
|
2022
Q2 | $4.32M | Buy |
312,476
+11,263
| +4% | +$180K | 0.02% | 728 |
|
|
2022
Q1 | $4.9M | Buy |
301,213
+65,217
| +28% | +$1.02M | 0.03% | 644 |
|
|
2021
Q4 | $3.84M | Sell |
235,996
-46,066
| -16% | -$777K | 0.02% | 812 |
|
|
2021
Q3 | $4.19M | Sell |
282,062
-41,174
| -13% | -$659K | 0.03% | 748 |
|
|
2021
Q2 | $6.46M | Sell |
323,236
-37,449
| -10% | -$742K | 0.04% | 548 |
|
|
2021
Q1 | $8.32M | Sell |
360,685
-10,639
| -3% | -$297K | 0.06% | 393 |
|
|
2020
Q4 | $9.17M | Buy |
371,324
+56,485
| +18% | +$1.87M | 0.08% | 290 |
|
|
2020
Q3 | $13.1M | Buy |
314,839
+280,437
| +815% | +$12.9M | 0.11% | 212 |
|
|
2020
Q2 | $1.65M | Buy |
34,402
+7,930
| +30% | +$613K | 0.02% | 682 |
|
|
2020
Q1 | $1.67M | Sell |
26,472
-1,329
| -5% | -$119K | 0.05% | 389 |
|
|
2019
Q4 | $3.44M | Buy |
27,801
+24,411
| +720% | +$2.19M | 0.07% | 366 |
|
|
2019
Q3 | $225K | Buy |
+3,390
| New | +$228K | ﹤0.01% | 985 |
|
|
2019
Q2 | – | Sell |
-5,574
| Closed | -$624K | – | 1164 |
|
|
2019
Q1 | $624K | Sell |
5,574
-5,301
| -49% | -$579K | 0.02% | 607 |
|
|
2018
Q4 | $1.1M | Buy |
+10,875
| New | +$1.13M | 0.05% | 262 |
|
|
2018
Q1 | – | Sell |
-16,424
| Closed | -$959K | – | 690 |
|
|
2017
Q4 | $959K | Buy |
16,424
+8,233
| +101% | +$519K | 0.02% | 378 |
|
|
2017
Q3 | $475K | Buy |
+8,191
| New | +$882K | 0.01% | 355 |
|
Voloridge Investment Management's ICPT Position: Q4 2023 in Review
Voloridge Investment Management sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2023, closing a stake of 56,353 shares — an estimated $1.04M sold.
Voloridge Investment Management first reported a position in ICPT in Q3 2017 and held it in 20 quarters. The position peaked at $13.1M in Q3 2020. 0 funds tracked by Wall St. Rank hold ICPT as of Q4 2023.
- Voloridge Investment Management reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
- Voloridge Investment Management sold 56,353 Intercept Pharmaceuticals, Inc. shares in Q4 2023, an estimated $1.04M.
- Voloridge Investment Management first reported a position in Intercept Pharmaceuticals, Inc. in Q3 2017 and held it in 20 quarters.
- Voloridge Investment Management's Intercept Pharmaceuticals, Inc. position peaked at $13.1M in Q3 2020.
- 0 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2023.
Based on Voloridge Investment Management's 13F filing for Q4 2023, filed 14 Feb 2024.